In addition, ALCAT1-targeted inactivation prevents diet-induced obesity, NAFLD, MPTP-induced neurotoxicity, improves motor deficiency, and inhibits apoptosis [19, 20, 23]. This evidence concerns the gene LCLAT1 and metabolic dysfunction-associated steatotic liver disease.